ALAUNOS THERAPEUTICS INC (TCRT)

US98973P2002 - Common Stock

1.23  -0.01 (-0.81%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
5.00K2.92M400.00K0.000.00
Operating Expenses
28.50M38.16M73.55M80.36M57.86M
Research and Development
16.28M25.02M47.28M52.70M38.33M
Selling, General, and Administrative Expenses
12.22M13.14M26.28M27.67M19.53M
Operating Income
-28.49M-35.24M-73.15M-80.36M-57.86M
Interest Income/Expense
-1.92M-3.15M-1.18MN/A0.00
Other Income/Expense
1.05M530.00K-20.00K390.00K-59.94M
Non Recurring Items
-5.77M130.00K-4.40MN/AN/A
Income Before Taxes
-35.14M-37.73M-78.75M-79.98M-117.80M
Net Income
-35.14M-37.73M-78.75M-79.98M-117.80M
EBITDA
-26.18M-32.48M-70.55M-79.23M-57.23M
 
Per Share Data
EPS Diluted Total Ops
-2.20-0.17-0.37-0.38-0.70
Non GAAP EPS
-2.29-0.74-0.37-0.39-0.69
 
Statistics
Profit Margin
-702800.00%-1292.12%-19687.50%N/AN/A
Operating Profit Margin
-569860.00%-1206.85%-18287.50%N/AN/A

All data in USD

Charts